Fennec Pharmaceuticals Inc. (FENC)
USD 5.66
(-6.75%)
USD 5.66
(-6.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Assets | 26.72 Million | 26.93 Million | 22.41 Million | 31.41 Million | 14.14 Million | 22.95 Million |
| Total Current Assets | 26.72 Million | 26.72 Million | 22.38 Million | 31.41 Million | 13.88 Million | 22.95 Million |
| Cash And Short Term Investments | 13.2 Million | 23.77 Million | 21.1 Million | 30.34 Million | 13.65 Million | 22.78 Million |
| Cash and Cash Equivalents | 13.2 Million | 23.77 Million | 21.1 Million | 30.34 Million | 13.65 Million | 22.78 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | 8.76 Million | 1.54 Million | - | - | - | - |
| Inventory | 2.14 Million | 576 Thousand | - | - | - | - |
| Other Current Assets | 2.6 Million | 63 Thousand | 253 Thousand | 276 Thousand | 234 Thousand | 169 Thousand |
| Total Non-Current Assets | 5969.30 | 211 Thousand | 27 Thousand | - | 262 Thousand | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 5969.30 | 211 Thousand | 27 Thousand | - | 262 Thousand | - |
| Other Assets | -0.30 | - | - | 1.07 Million | - | 169 Thousand |
| Total Liabilities | 38.28 Million | 29.5 Million | 6.64 Million | 2.34 Million | 2.27 Million | 1.63 Million |
| Total Current Liabilities | 7.51 Million | 4.6 Million | 1.65 Million | 2.34 Million | 2.27 Million | 1.63 Million |
| Account Payables | 3.75 Million | 2.39 Million | 777 Thousand | 1.57 Million | 1.61 Million | 1.03 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 20.89 Thousand | - | - | - | - | - |
| Deferred Revenue | -21 Thousand | - | - | - | - | - |
| Other Current Liabilities | 3.75 Million | 2.21 Million | 877 Thousand | 776 Thousand | 659 Thousand | 605 Thousand |
| Total Non Current Liabilities | 30.77 Million | 24.89 Million | 4.98 Million | - | - | 1.03 Million |
| Long-Term Debt | 29.55 Million | 24.89 Million | 4.98 Million | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 1.21 Million | - | -4.98 Million | - | - | - |
| Other Liabilities | 1.00 | - | - | - | - | -1.03 Million |
| Total Equity | -11.56 Million | -2.56 Million | 15.77 Million | 29.07 Million | 11.87 Million | 21.31 Million |
| Stock Holders Equity | -11.56 Million | -2.56 Million | 15.77 Million | 29.07 Million | 11.87 Million | 21.31 Million |
| Common Stock | 143.56 Million | 142.59 Million | 140.8 Million | 140.73 Million | 106.39 Million | 106.39 Million |
| Retained Earnings | -218.12 Million | -203.2 Million | -179.48 Million | -162.14 Million | -144.03 Million | -131.25 Million |
| Accumulated other comprehensive income | 1.23 Million | 1.24 Million | 1.24 Million | 1.24 Million | 1.24 Million | 1.24 Million |
| Common Stock Equity | -11.56 Million | -2.56 Million | 15.77 Million | 29.07 Million | 11.87 Million | 21.31 Million |
| Capital Lease Obligation | 1989.77 | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | 29.58 Million | 24.89 Million | 4.98 Million | - | - | - |
| Net Debt | 16.38 Million | 1.12 Million | -16.11 Million | -30.34 Million | -13.65 Million | -22.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 63.15 Million | 69.12 Million | 26.72 Million | 26.72 Million | 19.02 Million | 19.43 Million |
| Total Current Assets | 62.16 Million | 68.1 Million | 26.72 Million | 26.72 Million | 18.94 Million | 19.33 Million |
| Cash And Short Term Investments | 43.04 Million | 51.13 Million | 13.2 Million | 13.2 Million | 12.39 Million | 14.95 Million |
| Cash and Cash Equivalents | 43.04 Million | 51.13 Million | 13.2 Million | 13.2 Million | 12.39 Million | 14.95 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | 12.31 Million | 10.26 Million | 8.76 Million | 8.76 Million | 4.52 Million | 2.44 Million |
| Inventory | 2.14 Million | 2.06 Million | 2.14 Million | 2.14 Million | 1.75 Million | 1.43 Million |
| Other Current Assets | 4.66 Million | 4.64 Million | 2.6 Million | 2.6 Million | 20 Thousand | 32 Thousand |
| Total Non-Current Assets | 988.85 Thousand | 1.02 Million | 5969.30 | 5969.30 | 82 Thousand | 106 Thousand |
| Net PPE | - | - | - | - | 28.86 Thousand | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 988.85 Thousand | 1.02 Million | 5969.30 | 5969.30 | 53.13 Thousand | 106 Thousand |
| Other Assets | 1.00 | 1.00 | -0.30 | -0.30 | - | - |
| Total Liabilities | 64.5 Million | 66.11 Million | 38.28 Million | 38.28 Million | 29.55 Million | 29.16 Million |
| Total Current Liabilities | 7.74 Million | 9.82 Million | 7.51 Million | 7.51 Million | 3.91 Million | 3.77 Million |
| Account Payables | 4.44 Million | 5.19 Million | 3.75 Million | 3.75 Million | 2.94 Million | 3 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 11.99 Thousand | 16.98 Thousand | 20.89 Thousand | 20.89 Thousand | 21 Thousand | - |
| Deferred Revenue | 251.96 Thousand | 251.74 Thousand | 1.00 | -21 Thousand | - | - |
| Other Current Liabilities | 3.03 Million | 4.35 Million | 3.73 Million | 3.75 Million | 951 Thousand | 773 Thousand |
| Total Non Current Liabilities | 56.76 Million | 56.28 Million | 30.77 Million | 30.77 Million | 25.64 Million | 25.38 Million |
| Long-Term Debt | 29.74 Million | 29.7 Million | 29.55 Million | 29.55 Million | 25.64 Million | 25.38 Million |
| Deferred Revenue Non Current | 24.99 Million | 24.96 Million | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 2.02 Million | 1.61 Million | 1.21 Million | 1.21 Million | - | - |
| Other Liabilities | 1.00 | 1.00 | 1.00 | 1.00 | - | - |
| Total Equity | -1.35 Million | 3.01 Million | -11.56 Million | -11.56 Million | -10.53 Million | -9.72 Million |
| Stock Holders Equity | -1.35 Million | 3.01 Million | -11.56 Million | -11.56 Million | -10.53 Million | -9.72 Million |
| Common Stock | 145.25 Million | 144.78 Million | 143.56 Million | 143.56 Million | 143.56 Million | 143.34 Million |
| Retained Earnings | -211.92 Million | -206.19 Million | -218.12 Million | -218.12 Million | -216.56 Million | -214.69 Million |
| Accumulated other comprehensive income | 1.24 Million | 1.24 Million | 1.23 Million | 1.23 Million | 1.24 Million | 1.24 Million |
| Common Stock Equity | -1.35 Million | 3.01 Million | -11.56 Million | -11.56 Million | -10.53 Million | -9.72 Million |
| Capital Lease Obligation | 12 Thousand | 17 Thousand | 1989.77 | 1989.77 | 28 Thousand | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | 29.76 Million | 29.71 Million | 29.58 Million | 29.58 Million | 25.66 Million | 25.38 Million |
| Net Debt | -13.28 Million | -21.41 Million | 16.38 Million | 16.38 Million | 13.26 Million | 10.42 Million |
CCNTF
601699
NEA
BRY
TSL
VALIANTLAB